Cytokine profiles in maternal serum are candidates for predicting an optimal timing for the delivery in early-onset fetal growth restriction

被引:3
作者
Kawashima, Akihiro [1 ]
Oba, Tomohiro [1 ]
Yasuhara, Rika [2 ]
Sekiya, Bunbu [1 ]
Sekizawa, Akihiko [1 ]
机构
[1] Showa Univ, Dept Obstet & Gynecol, Sch Med, Tokyo, Japan
[2] Showa Univ, Div Pathol, Dept Oral Diagnost Sci, Sch Dent, Tokyo, Japan
基金
日本学术振兴会;
关键词
CD40; LIGAND; PREGNANCIES; HYPERTENSION; RISK; OUTCOMES; STRESS;
D O I
10.1002/pd.5679
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Objective We examined whether maternal serum cytokine profiles of mothers with early-onset fetal growth restriction (FGR) were associated with delivery within 2 weeks after sampling during the third trimester. Study design This exploratory prospective cross-sectional study included a total of 20 singleton fetuses with early-onset FGR and 31 healthy controls. Maternal serum samples during the early third trimester were analyzed for 23 cytokines. Results Of 20 fetuses with early-onset FGR, 14 had delivery within 2 weeks after sampling. Multivariate analysis revealed that maternal serum concentrations of soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) and soluble CD40 ligand (sCD40L) were independently associated with delivery within 2 weeks in early-onset FGR. Among cases of early-onset FGR, concentrations of almost all maternal serum cytokines were similar. Maternal serum sVEGFR-1 concentrations were high when delivery occurred within 2 weeks. Maternal serum sCD40L concentrations were elicited only in cases in which delivery within 2 weeks occurred due to fetal deterioration. Conclusion We identified two biomarkers, one specific for FGR and the other dependent on severity, that were significant components of angiogenic activities and inflammation factors. Imbalances in serum protein expression may have a substantial effect on the pathogenesis of FGR.
引用
收藏
页码:728 / 737
页数:10
相关论文
共 39 条
[1]   Planning management and delivery of the growth-restricted fetus [J].
Baschat, Ahmet A. .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2018, 49 :53-65
[2]   Circulating Levels of Inflammatory Markers in Intrauterine Growth Restriction [J].
Boutsikou, Theodora ;
Mastorakos, George ;
Kyriakakou, Marialena ;
Margeli, Alexandra ;
Hassiakos, Demetrios ;
Papassotiriou, Ioannis ;
Kanaka-Gantenbein, Christina ;
Malamitsi-Puchner, Ariadne .
MEDIATORS OF INFLAMMATION, 2010, 2010
[3]   Placental Endoplasmic Reticulum Stress and Oxidative Stress in the Pathophysiology of Unexplained Intrauterine Growth Restriction and Early Onset Preeclampsia [J].
Burton, G. J. ;
Yung, H. -W. ;
Cindrova-Davies, T. ;
Charnock-Jones, D. S. .
PLACENTA, 2009, 30 :S43-S48
[4]   Fetal response to maternal exercise in pregnancies with uteroplacental insufficiency [J].
Chaddha, V ;
Simchen, MJ ;
Hornberger, LK ;
Allen, VM ;
Fallah, S ;
Coates, AL ;
Roberts, A ;
Wilkes, DL ;
Schneiderman-Walker, J ;
Jaeggi, E ;
Kingdom, JCP .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (03) :995-999
[5]   Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia [J].
Chaiworapongsa, T ;
Romero, R ;
Kim, YM ;
Kim, GJ ;
Kim, MR ;
Espinoza, J ;
Bujold, E ;
Gonçalves, L ;
Gomez, R ;
Edwin, S ;
Mazor, M .
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2005, 17 (01) :3-18
[6]   Blockade of CD40 ligand for intercellular communication reduces hypertension, placental oxidative stress, and AT1-AA in response to adoptive transfer of CD4+ T lymphocytes from RUPP rats [J].
Cornelius, Denise C. ;
Castillo, Javier ;
Porter, Justin ;
Amaral, Lorena M. ;
Campbell, Nathan ;
Paige, Adrienne ;
Thomas, Alexia J. ;
Harmon, Ashlyn ;
Cunningham, Mark W., Jr. ;
Wallace, Kedra ;
Herse, Florian ;
Wallukat, Gerd ;
Dechend, Ralf ;
LaMarca, Babbette .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2015, 309 (10) :R1243-R1250
[7]   Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease [J].
Danese, S. ;
Scaldaferri, F. ;
Vetrano, S. ;
Stefanelli, T. ;
Graziani, C. ;
Repici, A. ;
Ricci, R. ;
Straface, G. ;
Sgambato, A. ;
Malesci, A. ;
Fiocchi, C. ;
Rutella, S. .
GUT, 2007, 56 (09) :1248-1256
[8]   Preventing stillbirths through improved antenatal recognition of pregnancies at risk due to fetal growth restriction [J].
Gardosi, J. ;
Giddings, S. ;
Buller, S. ;
Southam, M. ;
Williams, M. .
PUBLIC HEALTH, 2014, 128 (08) :698-702
[9]   Association between maternal serum cytokine profiles at 7-10 weeks' gestation and birthweight in small for gestational age infants [J].
Georgiou, Harry M. ;
Thio, Yulinda S. ;
Russell, Chris ;
Permezel, Michael ;
Heng, Yujing J. ;
Lee, Stephen ;
Tong, Stephen .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 (05) :415.e1-415.e12
[10]   Consensus definition of fetal growth restriction: a Delphi procedure [J].
Gordijn, S. J. ;
Beune, I. M. ;
Thilaganathan, B. ;
Papageorghiou, A. ;
Baschat, A. A. ;
Baker, P. N. ;
Silver, R. M. ;
Wynia, K. ;
Ganzevoort, W. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2016, 48 (03) :333-339